These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16145309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A, Gebara O, Vitale C, Wajngarten M, Leonardo F, Ramires JA, Fini M, Mercuro G, Rosano GM.
    Circulation; 2003 Jul 01; 107(25):3165-9. PubMed ID: 12796135
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of tibolone and conventional hormone replacement therapies on arterial and hepatic cholesterol accumulation and on circulating endothelin-1, vascular cell adhesion molecule-1, and E-selectin in surgically menopausal monkeys.
    Register TC, Wagner JD, Zhang L, Hall J, Clarkson TB.
    Menopause; 2002 Jul 01; 9(6):411-21. PubMed ID: 12439100
    [Abstract] [Full Text] [Related]

  • 5. A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
    Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM.
    Thromb Res; 2012 Jul 01; 130(1):45-51. PubMed ID: 22217510
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.
    Hu P, Greendale GA, Palla SL, Reboussin BA, Herrington DM, Barrett-Connor E, Reuben DB.
    Atherosclerosis; 2006 Apr 01; 185(2):347-52. PubMed ID: 16023653
    [Abstract] [Full Text] [Related]

  • 8. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen.
    Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T.
    Circulation; 2002 Mar 26; 105(12):1436-9. PubMed ID: 11914251
    [Abstract] [Full Text] [Related]

  • 9. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec 26; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of different hormone treatment on endothelial function in healthy postmenopausal women.
    Akman L, Duygu H, Akercan F, Ulukus M, Ozerkan F, Akin M.
    Gynecol Endocrinol; 2013 Sep 26; 29(9):867-72. PubMed ID: 23875965
    [Abstract] [Full Text] [Related]

  • 13. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG, Herrington DM.
    Climacteric; 2005 Dec 26; 8(4):317-26. PubMed ID: 16390766
    [Abstract] [Full Text] [Related]

  • 14. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 26; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide in postmenopausal women taking three different HRT regimens.
    Kesim MD, Aydin Y, Erdemir M, Atis A.
    Maturitas; 2005 Jan 10; 50(1):52-7. PubMed ID: 15590214
    [Abstract] [Full Text] [Related]

  • 16. Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability.
    Törmälä R, Appt S, Clarkson TB, Mueck AO, Seeger H, Mikkola TS, Ylikorkala O.
    Climacteric; 2008 Oct 10; 11(5):409-15. PubMed ID: 18781486
    [Abstract] [Full Text] [Related]

  • 17. Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers.
    Eilertsen AL, Sandvik L, Steinsvik B, Sandset PM.
    J Thromb Haemost; 2008 Jun 10; 6(6):928-34. PubMed ID: 18394014
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
    Zanger D, Yang BK, Ardans J, Waclawiw MA, Csako G, Wahl LM, Cannon RO.
    J Am Coll Cardiol; 2000 Nov 15; 36(6):1797-802. PubMed ID: 11092646
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.